CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
CASH FLOW FROM OPERATING ACTIVITIES
Net loss	$ (5,466,794)	$ (4,519,949)	$ (3,266,013)
Adjustments to reconcile net loss to net cash used in operating activities
Amortization	160,625	160,625	160,625
Depreciation	41,137	10,284	0
Stock-based compensation and warrants	368,633	404,150	704,480
(Increase) decrease in assets
Prepaid drug product for testing	(404,848)	(103,303)	143,636
Other current assets	(78,483)	(36,377)	(21,542)
Increase (decrease) in liabilities
Accounts payable and accrued expenses	375,439	267,073	(34,346)
Net cash used in operating activities	(5,004,291)	(3,817,497)	(2,313,160)
CASH FLOW FROM INVESTING ACTIVITIES
Purchase furniture, fixtures & equipment	0	(123,410)	0
Net cash used in investing activities	0	(123,410)	0
CASH FLOW FROM FINANCING ACTIVITIES
Net proceeds from sale of common stock	0	13,812,373	5,330,946
Net proceeds from exercise of common stock options	0	435,500	0
Net cash from financing activities	0	14,247,873	5,330,946
NET INCREASE (DECREASE) IN CASH	(5,004,291)	10,306,966	3,017,786
Cash, beginning of period	13,858,798	3,551,832	534,046
Cash, end of period	8,854,507	13,858,798	3,551,832
Cash paid for
Interest	0	0	0
Income taxes	0	0	0
Non-cash financing activities
Common stock issued to Placement Agent	$ 0	$ 0	$ 771,047